New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Published Jun 18, 2020

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
CAR T Cell Therapy Reeducates Immune System for People With Certain Types of Blood Cancer
NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients-- Two Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
What the New Ovarian Cancer Drug Combo Approval Means for Patients
NOW
PLAYING
HER2-Positive Metastatic Breast Cancer Treatment Options
NOW
PLAYING
Treatment Options for Metastatic Triple Negative Breast Cancer
NOW
PLAYING
Ovarian Cancer Decision Making
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.